Compare UAA & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UAA | HAE |
|---|---|---|
| Founded | 1996 | 1971 |
| Country | United States | United States |
| Employees | 14100 | N/A |
| Industry | Apparel | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.8B |
| IPO Year | N/A | 1996 |
| Metric | UAA | HAE |
|---|---|---|
| Price | $5.84 | $74.43 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 16 | 9 |
| Target Price | $6.48 | ★ $84.13 |
| AVG Volume (30 Days) | ★ 7.0M | 984.8K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.05 |
| Revenue | N/A | ★ $910,373,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.57 | $5.23 |
| P/E Ratio | ★ N/A | $37.52 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.13 | $47.32 |
| 52 Week High | $8.15 | $87.32 |
| Indicator | UAA | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 54.09 | 62.97 |
| Support Level | $5.39 | $48.98 |
| Resistance Level | $6.10 | $86.72 |
| Average True Range (ATR) | 0.24 | 3.25 |
| MACD | 0.07 | 0.53 |
| Stochastic Oscillator | 66.07 | 55.12 |
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and Latin America. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through wholesale partners, company-owned digital channels, and approximately 440 company-owned outlet and full-price stores. The Baltimore-based firm was founded in 1996 and is led by controlling shareholder Kevin Plank.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.